tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Tryptamine Therapeutics Announces Change in Substantial Shareholding
Company AnnouncementsTryptamine Therapeutics Announces Change in Substantial Shareholding
2d ago
TYP
Tryptamine Therapeutics Appoints New Company Secretary Amid Strategic Advancements
PremiumCompany Announcements
Tryptamine Therapeutics Appoints New Company Secretary Amid Strategic Advancements
5d ago
TYP
Tryptamine Therapeutics Enhances Director’s Stake Amid Strategic Growth
PremiumCompany Announcements
Tryptamine Therapeutics Enhances Director’s Stake Amid Strategic Growth
5d ago
TYP
Tryptamine Therapeutics Announces Director’s Interest Changes
PremiumCompany Announcements
Tryptamine Therapeutics Announces Director’s Interest Changes
5d ago
TYP
Tryptamine Therapeutics Updates Director’s Securities Holdings
PremiumCompany Announcements
Tryptamine Therapeutics Updates Director’s Securities Holdings
5d ago
TYP
Tryptamine Therapeutics Issues New Equity Securities
PremiumCompany AnnouncementsTryptamine Therapeutics Issues New Equity Securities
5d ago
TYP
Tryptamine Therapeutics Issues 162 Million Unquoted Equity Securities
Premium
Company Announcements
Tryptamine Therapeutics Issues 162 Million Unquoted Equity Securities
5d ago
TYP
Tryptamine Therapeutics Lists New Securities on ASX
Premium
Company Announcements
Tryptamine Therapeutics Lists New Securities on ASX
5d ago
TYP
Tryptamine Therapeutics Gains Shareholder Support and Advances Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Gains Shareholder Support and Advances Clinical Trials
16d ago
TYP
Tryptamine Therapeutics Reports Increased Losses Amid Revenue Decline
PremiumCompany Announcements
Tryptamine Therapeutics Reports Increased Losses Amid Revenue Decline
1M ago
TYP
Tryptamine Therapeutics Updates Security Issuance Proposal
PremiumCompany Announcements
Tryptamine Therapeutics Updates Security Issuance Proposal
2M ago
Tryptamine Therapeutics Updates Proposed Securities Issue
PremiumCompany Announcements
Tryptamine Therapeutics Updates Proposed Securities Issue
2M ago
TYP
Tryptamine Therapeutics Advances Psychedelic Therapy with Strong Clinical and Financial Progress
PremiumCompany AnnouncementsTryptamine Therapeutics Advances Psychedelic Therapy with Strong Clinical and Financial Progress
2M ago
Tryptamine Therapeutics Appoints New Auditor Amid Global Expansion
Premium
Company Announcements
Tryptamine Therapeutics Appoints New Auditor Amid Global Expansion
2M ago
Tryptamine Therapeutics Advances Psychedelic Therapy Trials and Secures Funding
Premium
Company Announcements
Tryptamine Therapeutics Advances Psychedelic Therapy Trials and Secures Funding
2M ago
TYP
Tryptamine Therapeutics Announces Change in Director’s Securities
PremiumCompany Announcements
Tryptamine Therapeutics Announces Change in Director’s Securities
3M ago
TYP
Tryptamine Therapeutics Announces Lapse of Director Options
PremiumCompany Announcements
Tryptamine Therapeutics Announces Lapse of Director Options
3M ago
TYP
Tryptamine Therapeutics Announces Change in Director’s Interest
PremiumCompany Announcements
Tryptamine Therapeutics Announces Change in Director’s Interest
3M ago
TYP
Tryptamine Therapeutics Announces Director’s Interest Change
PremiumCompany Announcements
Tryptamine Therapeutics Announces Director’s Interest Change
3M ago
TYP
Tryptamine Therapeutics to Present at Biotech Showcase 2025
PremiumCompany AnnouncementsTryptamine Therapeutics to Present at Biotech Showcase 2025
3M ago
TYP
Tryptamine Therapeutics Appoints BDO as New Auditor
Premium
Company Announcements
Tryptamine Therapeutics Appoints BDO as New Auditor
3M ago
TYP
Tryptamine’s TRP-8802 Shows Promise in IBS Trial
Premium
Company Announcements
Tryptamine’s TRP-8802 Shows Promise in IBS Trial
4M ago
TYP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >